{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:56:57Z","timestamp":1789390617862,"version":"build-2803163510"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Both primary aldosteronism and obstructive sleep apnea are well-known causes of hypertension and contribute to increased cardiovascular morbidity and mortality independently. However, the relationship between these two entities remains unclear, with studies demonstrating contradictory results. This review aims to collate and put into perspective current available research regarding the association between primary aldosteronism and obstructive sleep apnea. The relationship between these two entities, clinical characteristics, clinical implications, outcomes of treatment, potential causal links and mechanisms are hereby presented.<\/jats:p>","DOI":"10.3389\/fendo.2022.976979","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T07:36:33Z","timestamp":1664436993000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Primary aldosteronism and obstructive sleep apnea: What do we know thus far?"],"prefix":"10.3389","volume":"13","author":[{"given":"Huai Heng","family":"Loh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norlela","family":"Sukor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41371-019-0294-8","article-title":"Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea-what do we know so far","volume":"34","author":"Loh","year":"2020","journal-title":"J Hum Hypertens"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2019.07.001","article-title":"The prevalence of primary aldosteronism and evolving approaches for treatment","volume":"8","author":"Yozamp","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00522.2007","article-title":"Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance","volume":"293","author":"Cooper","year":"2007","journal-title":"Am J Physiol Heart Circulatory Physiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.03.038","article-title":"Aldosterone blockade: an emerging strategy for abrogating progressive renal disease","volume":"119","author":"Epstein","year":"2006","journal-title":"Am J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030490","article-title":"50th anniversary of aldosterone","volume":"88","author":"Williams","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3949\/ccjm.86.s1.02","article-title":"Obstructive sleep apnea basics","volume":"86","author":"Rundo","year":"2019","journal-title":"Cleve Clin J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11906-018-0819-5","article-title":"Role of mineralocorticoid receptors in obstructive sleep apnea and metabolic syndrome","volume":"20","author":"Valaiyapathi","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v5.i3.381","article-title":"Diabetes, sleep apnea, obesity and cardiovascular disease: Why not address them together","volume":"5","author":"Surani","year":"2014","journal-title":"World J Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084362","article-title":"Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment","volume":"9","author":"Barcel\u00f3","year":"2014","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.2.309","article-title":"Renin activity and blood pressure in response to chronic episodic hypoxia","volume":"34","author":"Fletcher","year":"1999","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13833","article-title":"Primary aldosteronism and obstructive sleep apnea: A cross-sectional multi-ethnic study","volume":"74","author":"Buffolo","year":"2019","journal-title":"Hypertension"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e25049","DOI":"10.1097\/MD.0000000000025049","article-title":"Primary aldosteronism and obstructive sleep apnea: A single-center cross-sectional study of the Japanese population","volume":"100","author":"Nakamura","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5603\/EP.2013.0019","article-title":"Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension","volume":"64","author":"Prejbisz","year":"2013","journal-title":"Endokrynol Pol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2017.28","article-title":"Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea","volume":"31","author":"Wolley","year":"2017","journal-title":"J Hum hypertension"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199912000-00007","article-title":"A comparison of Asian and white patients with obstructive sleep apnea syndrome","volume":"109","author":"Li","year":"1999","journal-title":"Laryngoscope"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00118609","article-title":"Cross-cultural comparison of the sleep-disordered breathing prevalence among americans and Japanese","volume":"36","author":"Yamagishi","year":"2010","journal-title":"Eur Respir J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00157","article-title":"The blood pressure sensitivity to changes in sodium intake is similar in asians, blacks and whites. an analysis of 92 randomized controlled trials","volume":"6","author":"Graudal","year":"2015","journal-title":"Front Physiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2009.96","article-title":"Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report","volume":"24","author":"Gaddam","year":"2010","journal-title":"J Hum hypertension"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2015.1131290","article-title":"Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea","volume":"38","author":"Yang","year":"2016","journal-title":"Clin Exp Hypertens"},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jss.2018.10.040","article-title":"Treatment of primary aldosteronism reduces the probability of obstructive sleep apnea","volume":"236","author":"Wang","year":"2019","journal-title":"J Surg Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2011.47","article-title":"Resistant hypertension, obstructive sleep apnoea and aldosterone","volume":"26","author":"Dudenbostel","year":"2012","journal-title":"J Hum Hypertens"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(01)02222-1","article-title":"Laragh's lessons in pathophysiology and clinical pearls for treating hypertension","volume":"14","author":"Laragh","year":"2001","journal-title":"Am J Hypertens"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1442","article-title":"Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension","volume":"131","author":"Pratt-Ubunama","year":"2007","journal-title":"Chest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27878","article-title":"Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension","volume":"6","author":"Gonzaga","year":"2010","journal-title":"J Clin sleep Med JCSM Off Publ Am Acad Sleep Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01131.2007","article-title":"Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats","volume":"294","author":"Zhang","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.05.009","article-title":"Obstructive sleep apnea and diabetes: A state of the art review","volume":"152","author":"Reutrakul","year":"2017","journal-title":"Chest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.708537","article-title":"Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the framingham offspring study","volume":"116","author":"Ingelsson","year":"2007","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0675","article-title":"A population-based study of the bidirectional association between obstructive sleep apnea and type 2 diabetes in three prospective U.S. cohorts","volume":"41","author":"Huang","year":"2018","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-2004","article-title":"Risk of incident obstructive sleep apnea among patients with type 2 diabetes","volume":"42","author":"Subramanian","year":"2019","journal-title":"Diabetes Care"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.4610","article-title":"Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat","volume":"11","author":"Iftikhar","year":"2015","journal-title":"J Clin sleep Med JCSM Off Publ Am Acad Sleep Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.112.1.145","article-title":"Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients","volume":"112","author":"Tantucci","year":"1997","journal-title":"Chest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.peptides.2014.03.008","article-title":"Elevated plasma levels of soluble (pro)renin receptor in patients with obstructive sleep apnea syndrome: association with polysomnographic parameters","volume":"56","author":"Nishijima","year":"2014","journal-title":"Peptides"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8960","article-title":"Primary aldosteronism is highly prevalent in patients with hypertension and moderate to severe obstructive sleep apnea","volume":"17","author":"Dobrowolski","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0031","article-title":"Primary aldosteronism in diabetic subjects with resistant hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519868337","article-title":"Changes of aldosterone levels in patients with type 2 diabetes complicated by moderate to severe obstructive sleep apnea-hypopnea syndrome before and after treatment with continuous positive airway pressure","volume":"47","author":"Zhang","year":"2019","journal-title":"J Int Med Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0526OC","article-title":"Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea","volume":"190","author":"Nicholl","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1001-9294(11)60013-8","article-title":"Changes in plasma angiotensin II and circadian rhythm of blood pressure in hypertensive patients with sleep apnea syndrome before and after treatment","volume":"26","author":"Wang","year":"2011","journal-title":"Chin Med Sci J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1701261","DOI":"10.1183\/13993003.01261-2017","article-title":"The effect of treatment for sleep apnoea on determinants of blood pressure control","volume":"50","author":"Casitas","year":"2017","journal-title":"Eur Respir J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2869.1996.t01-1-00007.x","article-title":"Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea","volume":"5","author":"Saarelainen","year":"1996","journal-title":"J sleep Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.09.123","article-title":"Respective effects of OSA treatment and angiotensin receptor blocker on aldosterone in hypertensive OSA patients: a randomized cross-over controlled trial","volume":"177","author":"Lacedonia","year":"2014","journal-title":"Int J Cardiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001254","article-title":"Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension: a randomized controlled trial","volume":"35","author":"de Souza","year":"2017","journal-title":"J hypertension"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.06.1315","article-title":"Precision medicine in patients with resistant hypertension and obstructive sleep apnea: Blood pressure response to continuous positive airway pressure treatment","volume":"66","author":"Sanchez-de-la-Torre","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00318","article-title":"Continuous positive airway pressure reduces night-time blood pressure and heart rate in patients with obstructive sleep apnea and resistant hypertension: The RHOOSAS randomized controlled trial","volume":"9","author":"Joyeux-Faure","year":"2018","journal-title":"Front Neurol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2003.01212.x","article-title":"Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea","volume":"254","author":"Meston","year":"2003","journal-title":"J Internal Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)03267-3","article-title":"Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea","volume":"16","author":"Moller","year":"2003","journal-title":"Am J Hypertens"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-0085","article-title":"Effects of OSA treatment on BP in patients with resistant hypertension: A randomized trial","volume":"144","author":"Pedrosa","year":"2013","journal-title":"Chest"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/145.6.1367","article-title":"Diurnal and nocturnal diuresis and natriuresis in obstructive sleep apnea. effects of nasal continuous positive airway pressure therapy","volume":"145","author":"Rodenstein","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/32.12.1589","article-title":"Obstructive sleep apnea and aldosterone","volume":"32","author":"Svatikova","year":"2009","journal-title":"Sleep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1390023","article-title":"Obstructive sleep apnea: role of intermittent hypoxia and inflammation","volume":"35","author":"May","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00152.2001","article-title":"Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system","volume":"92","author":"Fletcher","year":"2002","journal-title":"J Appl Physiol (Bethesda Md 1985)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.13294\/j.aps.2014.0004","article-title":"Mechanisms of maladaptive responses of peripheral chemoreceptors to intermittent hypoxia in sleep-disordered breathing","volume":"66","author":"Fung","year":"2014","journal-title":"Sheng Li Xue Bao"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2013.074591","article-title":"Upregulation of a local renin-angiotensin system in the rat carotid body during chronic intermittent hypoxia","volume":"99","author":"Lam","year":"2014","journal-title":"Exp Physiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1988.254.3.R431","article-title":"Renin, ACTH, and aldosterone during acute hypercapnia and hypoxia in conscious rats","volume":"254","author":"Raff","year":"1988","journal-title":"Am J Physiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.09.011","article-title":"The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism","volume":"350","author":"Marzolla","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11906-016-0626-9","article-title":"Aldosterone production and signaling dysregulation in obesity","volume":"18","author":"Vecchiola","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000116223.97436.e5","article-title":"Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-3278(99)80020-9","article-title":"Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans","volume":"60","author":"Goodfriend","year":"1999","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000052314.95497.78","article-title":"The kidney, hypertension, and obesity","volume":"41","author":"Hall","year":"2003","journal-title":"Hypertension"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.35.6.1270","article-title":"Physiology and pathophysiology of the adipose tissue renin-angiotensin system","volume":"35","author":"Engeli","year":"2000","journal-title":"Hypertension"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328017f6d5","article-title":"Interaction between the angiotensin-converting enzyme gene insertion\/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension","volume":"25","author":"Bostr\u00f6m","year":"2007","journal-title":"J hypertension"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4238\/vol9-2gmr755","article-title":"Lack of association of ACE gene I\/D polymorphism with obstructive sleep apnea syndrome in Turkish patients","volume":"9","author":"Yakut","year":"2010","journal-title":"Genet Mol Res GMR."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s100380070019","article-title":"Association of essential hypertension in elderly Japanese with I\/D polymorphism of the angiotensin-converting enzyme (ACE) gene","volume":"45","author":"Yoshida","year":"2000","journal-title":"J Hum Genet"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.976979\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T07:36:39Z","timestamp":1664436999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.976979\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":67,"alternative-id":["10.3389\/fendo.2022.976979"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.976979","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"article-number":"976979"}}